Affinity- and epitope-dependent pathogenicity of GM-CSF autoantibodies in patients with autoimmune pulmonary alveolar proteinosis.
Saved in:
| Title: | Affinity- and epitope-dependent pathogenicity of GM-CSF autoantibodies in patients with autoimmune pulmonary alveolar proteinosis. |
|---|---|
| Authors: | Futami S; Laboratory of Lymphocyte Differentiation, WPI Immunology Frontier Research Center, The University of Osaka, Osaka, Japan.; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, The University of Osaka, Osaka, Japan.; Department of Respiratory Medicine, NHO Osaka National Hospital, Osaka, Japan., Kawai C; Laboratory of Lymphocyte Differentiation, WPI Immunology Frontier Research Center, The University of Osaka, Osaka, Japan., Kishikawa JI; Laboratory of Cryo-EM Structural Biology, Institute for Protein Research, The University of Osaka, Osaka, Japan.; Faculty of Applied Biology, Kyoto Institute of Technology, Kyoto, Japan., Hirose M; Clinical Research Center, NHO Kinki Chuo Chest Medical Center, Osaka, Japan., Kida H; Department of Respiratory Medicine, NHO Osaka Toneyama Medical Center, Osaka, Japan., Wang PH; KOTAI Biotechnologies, Inc., Osaka, Japan., Yamashita K; KOTAI Biotechnologies, Inc., Osaka, Japan., Ishikawa F; Laboratory for Human Disease Models, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan., Kato T; Laboratory of Cryo-EM Structural Biology, Institute for Protein Research, The University of Osaka, Osaka, Japan., Inoue Y; Clinical Research Center, NHO Kinki Chuo Chest Medical Center, Osaka, Japan.; Department of Internal Medicine, Osaka Anti-tuberculosis Association, Osaka Fukujuji Hospital, Osaka, Japan., Kumanogoh A; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, The University of Osaka, Osaka, Japan.; Department of Immunopathology, WPI Immunology Frontier Research Center, The University of Osaka, Osaka, Japan.; Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), The University of Osaka, Osaka, Japan.; Center for Infectious Disease Education and Research (CiDER), The University of Osaka, Osaka, Japan.; Japan Agency for Medical Research and Development - Core Research for Evolutional Science and Technology (AMED-CREST), The University of Osaka, Osaka, Japan.; Center for Advanced Modalities and DDS (CAMaD), The University of Osaka, Osaka, Japan., Kurosaki T; Laboratory of Lymphocyte Differentiation, WPI Immunology Frontier Research Center, The University of Osaka, Osaka, Japan. kurosaki@ifrec.osaka-u.ac.jp.; Laboratory for Lymphocyte Differentiation, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan. kurosaki@ifrec.osaka-u.ac.jp., Inoue T; Laboratory of Lymphocyte Differentiation, WPI Immunology Frontier Research Center, The University of Osaka, Osaka, Japan. takeshi-inoue@g.ecc.u-tokyo.ac.jp.; Department of Molecular Systems Immunology, The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Tokyo, Japan. takeshi-inoue@g.ecc.u-tokyo.ac.jp.; International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. takeshi-inoue@g.ecc.u-tokyo.ac.jp. |
| Source: | Nature communications [Nat Commun] 2026 Jun 26; Vol. 17 (1). Date of Electronic Publication: 2026 Jun 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42362542 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Affinity- and epitope-dependent pathogenicity of GM-CSF autoantibodies in patients with autoimmune pulmonary alveolar proteinosis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Futami+S%22">Futami S</searchLink>; Laboratory of Lymphocyte Differentiation, WPI Immunology Frontier Research Center, The University of Osaka, Osaka, Japan.; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, The University of Osaka, Osaka, Japan.; Department of Respiratory Medicine, NHO Osaka National Hospital, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Kawai+C%22">Kawai C</searchLink>; Laboratory of Lymphocyte Differentiation, WPI Immunology Frontier Research Center, The University of Osaka, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Kishikawa+JI%22">Kishikawa JI</searchLink>; Laboratory of Cryo-EM Structural Biology, Institute for Protein Research, The University of Osaka, Osaka, Japan.; Faculty of Applied Biology, Kyoto Institute of Technology, Kyoto, Japan.<br /><searchLink fieldCode="AU" term="%22Hirose+M%22">Hirose M</searchLink>; Clinical Research Center, NHO Kinki Chuo Chest Medical Center, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Kida+H%22">Kida H</searchLink>; Department of Respiratory Medicine, NHO Osaka Toneyama Medical Center, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Wang+PH%22">Wang PH</searchLink>; KOTAI Biotechnologies, Inc., Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Yamashita+K%22">Yamashita K</searchLink>; KOTAI Biotechnologies, Inc., Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Ishikawa+F%22">Ishikawa F</searchLink>; Laboratory for Human Disease Models, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan.<br /><searchLink fieldCode="AU" term="%22Kato+T%22">Kato T</searchLink>; Laboratory of Cryo-EM Structural Biology, Institute for Protein Research, The University of Osaka, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Inoue+Y%22">Inoue Y</searchLink>; Clinical Research Center, NHO Kinki Chuo Chest Medical Center, Osaka, Japan.; Department of Internal Medicine, Osaka Anti-tuberculosis Association, Osaka Fukujuji Hospital, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Kumanogoh+A%22">Kumanogoh A</searchLink>; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, The University of Osaka, Osaka, Japan.; Department of Immunopathology, WPI Immunology Frontier Research Center, The University of Osaka, Osaka, Japan.; Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), The University of Osaka, Osaka, Japan.; Center for Infectious Disease Education and Research (CiDER), The University of Osaka, Osaka, Japan.; Japan Agency for Medical Research and Development - Core Research for Evolutional Science and Technology (AMED-CREST), The University of Osaka, Osaka, Japan.; Center for Advanced Modalities and DDS (CAMaD), The University of Osaka, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Kurosaki+T%22">Kurosaki T</searchLink>; Laboratory of Lymphocyte Differentiation, WPI Immunology Frontier Research Center, The University of Osaka, Osaka, Japan. kurosaki@ifrec.osaka-u.ac.jp.; Laboratory for Lymphocyte Differentiation, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan. kurosaki@ifrec.osaka-u.ac.jp.<br /><searchLink fieldCode="AU" term="%22Inoue+T%22">Inoue T</searchLink>; Laboratory of Lymphocyte Differentiation, WPI Immunology Frontier Research Center, The University of Osaka, Osaka, Japan. takeshi-inoue@g.ecc.u-tokyo.ac.jp.; Department of Molecular Systems Immunology, The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Tokyo, Japan. takeshi-inoue@g.ecc.u-tokyo.ac.jp.; International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. takeshi-inoue@g.ecc.u-tokyo.ac.jp. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2026 Jun 26; Vol. 17 (1). <i>Date of Electronic Publication: </i>2026 Jun 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42362542 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-026-74717-2 Languages: – Code: eng Text: English Titles: – TitleFull: Affinity- and epitope-dependent pathogenicity of GM-CSF autoantibodies in patients with autoimmune pulmonary alveolar proteinosis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Futami S – PersonEntity: Name: NameFull: Kawai C – PersonEntity: Name: NameFull: Kishikawa JI – PersonEntity: Name: NameFull: Hirose M – PersonEntity: Name: NameFull: Kida H – PersonEntity: Name: NameFull: Wang PH – PersonEntity: Name: NameFull: Yamashita K – PersonEntity: Name: NameFull: Ishikawa F – PersonEntity: Name: NameFull: Kato T – PersonEntity: Name: NameFull: Inoue Y – PersonEntity: Name: NameFull: Kumanogoh A – PersonEntity: Name: NameFull: Kurosaki T – PersonEntity: Name: NameFull: Inoue T IsPartOfRelationships: – BibEntity: Dates: – D: 26 M: 06 Text: 2026 Jun 26 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 17 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |